Search Within

MSK Grad Students

  1. "Master of Science in Clinical and Translational Cancer Research "
Formats
  1. Meeting Abstract (519)
  2. Journal Article (329)
  3. Review (40)
  4. Miscellaneous (16)
  5. Research Letter (15)
  6. Editorial (14)
  7. Correspondence (12)
  8. Conference Paper (4)
  9. Book Section (3)
  10. Guidelines (3)
Groups
  1. CTCR Scholars (955)
  2. Master of Science in Clinical and Translational Cancer Research (955)
  3. Department of Medicine (853)
  4. Hematologic Malignancies, Division of (651)
  5. Center for Hematologic Malignancies (630)
  6. Survivorship Research (578)

More Groups

People
  1. Sergio Giralt (378)
  2. Miguel-Angel Perales (356)
  3. Parastoo Dahi (294)
  4. Sean Devlin (265)
  5. Doris Ponce (254)
  6. Roni Tamari (208)

More People

Years
  1. 2025 (41)
  2. 2024 (109)
  3. 2023 (140)
  4. 2022 (121)
  5. 2021 (104)
  6. 2020 (119)

More Years

Publications
  1. Blood (191)
  2. Biology of Blood and Marrow Transplantation (153)
  3. Journal of Clinical Oncology (79)
  4. Annals of Surgical Oncology (78)
  5. Bone Marrow Transplantation (55)
  6. Transplantation and Cellular Therapy (42)

More Publications

Publishers
  1. American Society of Hematology (223)
  2. Elsevier Inc. (219)
  3. Springer (90)
  4. American Society of Clinical Oncology (87)
  5. Nature Publishing Group (82)
  6. American Association for Cancer Research (29)

More Publishers

Results (955)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Successful incorporation of electronic patient-reported outcomes using PROMIS-29 into standard of care for lymphoma patients receiving CD19-directed chimeric antigen receptor T (CAR T) cell therapy
    Meeting Abstract

    Shah, G. L.; Scordo, M.; Sauter, C.; Batlevi, C.; Dahi, P. B.; Lin, R.; Palomba, M. L.; Perales, M. A.; Giralt, S. A.
    Quality of Life Research (2021)

    Fulltext@MSK | Save
  • Alterations in driver genes are associated with response to neoadjuvant FOLFIRINOX in patients with nonmetastatic pancreatic ductal adenocarcinoma
    Meeting Abstract

    Ecker, B. L.; Janssen, Q.; Tao, A.; Tansey, W.; D'Angelica, M.; Drebin, J. A.; Jarnagin, W. R.; Kingham, T. P.; Soares, K.; Wei, A. C.
    Journal of the American College of Surgeons (2021)

    Fulltext@MSK | Save
  • Real-world pan-cancer landscape of frameshift mutations (FSM) and their role in predicting responses to immune checkpoint inhibitors (ICI) in patients (pts) with tumors with low tumor mutational burden (TMB)
    Meeting Abstract

    Florou, V.; Floudas, C. S.; Maoz, A.; Naqash, A. R.; Hildebrand, G.; Sokol, E.; Frampton, G. M.; Puri, S.; Swami, U.; Wilky, B. A.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Phase II trial of olaparib in combination with ceralasertib in patients with recurrent osteosarcoma
    Meeting Abstract

    Forrest, S. J.; Kinnaman, M. D.; Livingston, J. A.; Vo, K. T.; Merriam, P.; Clinton, C.; Desmith, K.; Cavanaugh, K.; Felicetti, B.; Smith, S.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Preliminary clinical and biologic results of GB1275, a first-in-class oral CD11b modulator, alone and with pembrolizumab, in advanced solid tumors (KEYNOTE A36)
    Meeting Abstract

    Park, H.; Bendell, J. C.; Messersmith, W. A.; Rasco, D. W.; De Bono, J. S.; Strickler, J. H.; Zhou, L.; Carter, L. L.; Bruey, J. M.; Li, J.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Update of a phase II, multicenter study of high-dose chemotherapy with autologous stem cell transplant followed by maintenance romidepsin for T-cell lymphoma
    Meeting Abstract

    Khan, N.; Khimani, F.; Shustov, A. R.; Shadman, M.; Ruan, J.; Moskowitz, A. J.; Straus, D. J.; Kumar, A.; Sauter, C. S.; Zelenetz, A. D.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Outcomes of allogeneic hematopoietic cell transplantation in patients with myelofibrosis: A systematic review and meta-analysis
    Meeting Abstract

    Bewersdorf, J. P.; Sheth, A.; Vetsa, S.; Grimshaw, A.; Giri, S.; Podoltsev, N. A.; Gowda, L.; Tamari, R.; Tallman, M. S.; Rampal, R.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • High quality neoantigens are immunoedited in long-term pancreatic cancer survivors
    Meeting Abstract

    Rojas, L. A.; Łuksza, M.; Sethna, Z. M.; Soares, K.; Leung, J.; Lihm, J.; Hoyos, D.; Dobrin, A.; Kappagantula, R.; Makohon-Moore, A.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Oral proteasome inhibitor ixazomib for switch-maintenance prophylaxis of recurrent or late acute and chronic graft-versus-host disease after day 100 in allogeneic stem cell transplantation
    Journal Article

    Rodriguez, N.; Lee, J.; Flynn, L.; Murray, F.; Devlin, S. M.; Soto, C.; Cho, C.; Dahi, P.; Giralt, S.; Perales, M. A.; more...
    Transplantation and Cellular Therapy (2021)

    Fulltext@MSK | Save
  • Outcomes of allogeneic hematopoietic cell transplantation in patients with myelofibrosis: A systematic review and meta-analysis
    Review

    Bewersdorf, J. P.; Sheth, A. H.; Vetsa, S.; Grimshaw, A.; Giri, S.; Podoltsev, N. A.; Gowda, L.; Tamari, R.; Tallman, M. S.; Rampal, R. K.; more...
    Transplantation and Cellular Therapy (2021)

    Fulltext@MSK | Save